文献速递前列腺癌男科与性医学

前列腺癌诊断后自杀发生率与危险因素的观察性研究荟萃分析

Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2018-08-14

该荟萃分析纳入8项观察性研究,比较前列腺癌患者与非癌匹配男性的自杀风险。结果显示前列腺癌诊断后第一年自杀风险升高(RR=2.01),尤其前6个月(RR=2.24),75岁以上及接受激素治疗者风险亦增加。

要点

  • 前列腺癌诊断后第一年自杀风险为无癌男性的2.01倍,前6个月达2.24倍。
  • 75岁及以上患者自杀风险升高(RR=1.51),接受激素治疗者亦升高(RR=1.80)。
  • 婚姻状态、种族、疾病风险分级和社会经济状态与自杀风险升高无关。

核心结论

  • 前列腺癌诊断后自杀风险升高,尤其见于75岁以上、诊断后12个月内及接受激素治疗的患者。

研究设计与样本

  • 荟萃分析纳入8项观察性研究,包括1,281,393例前列腺癌患者和842,294例匹配的无前列腺癌男性。

主要发现

  • 诊断后第一年自杀汇总RR为2.01(95%CI:1.52-2.64;P<0.001;I2=91.8%)。
  • 诊断后前6个月自杀RR为2.24(95%CI:1.77-2.85;P<0.001;I2=61.1%)。
  • 75岁及以上患者自杀RR为1.51(95%CI:1.04-2.18;P=0.028;I2=91.5%)。
  • 接受激素治疗者自杀RR为1.80(95%CI:1.54-2.12;P<0.001;I2=0%)。
  • 婚姻状态、种族、疾病风险分级和社会经济状态与自杀风险升高无关。

临床怎么用

  • 医疗提供者应识别前列腺癌诊断后高自杀风险人群,尤其是75岁以上、诊断后12个月内及接受激素治疗者。

局限性

  • 需进一步研究以完善自杀风险评估工具并制定最佳预防实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether the diagnosis of prostate cancer is a contributory psychological stress that causes excess risk of suicide among affected men remains controversial. We performed a meta-analysis of previous studies to investigate suicide incidence and associated risk factors among men diagnosed with prostate cancer. METHODS: The MEDLINE, Embase, Cochrane Library, and PsycINFO databases were searched to identify eligible studies published before April 2018. The inverse variance method with random-effects modeling was used to calculate summary relative risks (RRs) and their associated 95% confidence intervals (CIs). RESULTS: Eight observational studies involving 1,281,393 men diagnosed with prostate cancer and 842,294 matched prostate cancer-free men were included. An overall increased RR of suicide of 2.01 (95% CI: 1.52-2.64; P < 0.001; I2 = 91.8%) was observed among men diagnosed with prostate cancer compared with those without prostate cancer during the first year, especially during the first 6 months (RR = 2.24, 95% CI: 1.77-2.85; P < 0.001; I2 = 61.1%) after diagnosis. Moreover, prostate cancer patients were at an increased risk of suicide among men aged 75 years or older (RR = 1.51, 95% CI: 1.04-2.18; P = 0.028; I2 = 91.5%) and treated with hormonal therapy (RR = 1.80, 95% CI: 1.54-2.12; P < 0.001; I2 = 0%). Furthermore, marital status, race, disease risk category, and socioeconomic status were not associated with increased suicide risk in men with prostate cancer. CONCLUSIONS: Current evidence indicates that the risk of suicide is increased among men diagnosed with prostate cancer, particularly those aged 75 years or older, <12 months after diagnosis, and treated with hormonal therapy. Healthcare providers should be aware of these special populations considered at high risk of suicide. Hence, further research should be conducted to refine suicide risk assessment with detection tools and to develop the best practices for prevention.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Guo Z, Gan S, Li Y, et al. Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis. 2018. PMID: 30108374. doi:10.1038/s41391-018-0073-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。